Bevacizumab (Bev) plus chemotherapy for advanced gastroesophageal adenocarcinoma (GC): Combined U.S. experience.
E. C. Smyth
No relevant relationships to disclose
P. C. Enzinger
Consultant or Advisory Role - Genentech
Research Funding - Genentech
J. Li
No relevant relationships to disclose
M. Vincitore
No relevant relationships to disclose
J. Lacy
No relevant relationships to disclose
B. F. El-Rayes
No relevant relationships to disclose
P. L. Kunz
Research Funding - Genentech
J. M. Ford
No relevant relationships to disclose
E. Robinson
No relevant relationships to disclose
D. P. Kelsen
No relevant relationships to disclose
M. A. Shah
No relevant relationships to disclose